Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes

Synthesis of azide derivative and discovery of glyoxalase pathway inhibitor against pathogenic bacteria

(2013) Benson Edagwa et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Advances in nanotechnology for diagnosis and treatment of tuberculosis

(2013) Shelza Banyal et al.   CURRENT OPINION IN PULMONARY MEDICINE

An Isoniazid Analogue Promotes Mycobacterium tuberculosis-Nanoparticle Interactions and Enhances Bacterial Killing by Macrophages

(2012) Tatiany J. de Faria et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tuberculosis: from molecular pathogenesis to effective drug carrier design

(2012) Devyani Dube et al.   DRUG DISCOVERY TODAY

Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages

(2012) Shann Yu et al.   International Journal of Nanomedicine

Global tuberculosis control: lessons learnt and future prospects

(2012) Christian Lienhardt et al.   NATURE REVIEWS MICROBIOLOGY

Tuberculosis and HIV Co-Infection

(2012) Andrzej Pawlowski et al.   PLoS Pathogens

Cell-mediated drug delivery

(2011) Elena V Batrakova et al.   Expert Opinion on Drug Delivery

Tuberculosis

(2011) Stephen D Lawn et al.   LANCET

Role of innate cytokines in mycobacterial infection

(2011) A M Cooper et al.   Mucosal Immunology

Macrophage endocytic trafficking of antiretroviral nanoparticles

(2011) Irena Kadiu et al.   Nanomedicine

Nanomedicine and experimental tuberculosis: facts, flaws, and future

(2011) Rajesh Pandey et al.   Nanomedicine-Nanotechnology Biology and Medicine

Interleukin-6

(2010) STEVEN C. CLARK   Annals of the New York Academy of Sciences

Synthesis of 4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate and Kinetic Studies of Mycobacterium tuberculosis IspF

(2010) Prabagaran Narayanasamy et al.   CHEMISTRY & BIOLOGY

HIV Infection–Associated Tuberculosis: The Epidemiology and the Response

(2010) Haileyesus Getahun et al.   CLINICAL INFECTIOUS DISEASES

Tuberculosis: What We Don't Know Can, and Does, Hurt Us

(2010) D. G. Russell et al.   SCIENCE

New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery

(2009) Alejandro Sosnik et al.   ADVANCED DRUG DELIVERY REVIEWS

Expression and Characterization of Soluble 4-Diphosphocytidyl-2-C-methyl-D-erythritol Kinase from Bacterial Pathogens

(2009) Hyungjin Eoh et al.   CHEMISTRY & BIOLOGY

Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid

(2009) Michael J. Hearn et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Lazy, Dynamic or Minimally Recrudescent? On the Elusive Nature and Location of the Mycobacterium Responsible for Latent Tuberculosis

(2009) S. Ehlers   INFECTION

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte–macrophage drug delivery

(2009) Ari S Nowacek et al.   Nanomedicine

Point-of-Care Diagnostics for Global Health

(2008) Paul Yager et al.   Annual Review of Biomedical Engineering

Mycobacterial manipulation of vacuolar sorting

(2008) Jennifer A. Philips   CELLULAR MICROBIOLOGY

Nanotechnology for Nanomedicine and Delivery of Drugs

(2008) J. Venugopal et al.   CURRENT PHARMACEUTICAL DESIGN

Intracellular Drug Delivery by Poly(lactic-co-glycolic acid) Nanoparticles, Revisited

(2008) Peisheng Xu et al.   MOLECULAR PHARMACEUTICS

The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line

(2008) Martin J.D. Clift et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY